Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Analyticon Biotechnologies AG
WARNING LETTER
•Analyticon Biotechnologies AG•March 29, 2012

Analyticon Biotechnologies AG – FDA Warning Letter, Mar 29, 2012

Record Details

On August 10, 2012, the FDA issued a Warning Letter to Analyticon Biotechnologies AG following an inspection from March 26-29, 2012, which found their Combi Screen Urine Test Strips to be adulterated. The inspection revealed non-conformity with Quality System (QS) regulation (21 CFR Part 820).

Key violations include: 1. **Corrective and Preventive Action (CAPA) Procedures (21 CFR 820.100(a)(1)):** The firm's CAPA procedure (VA_AU_OR_006) lacks statistical methodology for analyzing data sources like complaints and non-conformities to determine when CAPA is required. Their response was inadequate, failing to specify how complaint trends would trigger CAPAs. 2. **Inspection, Measuring, and Test Equipment (21 CFR 820.72(a)):** The firm used unvalidated equipment for in-process and final QC testing of Combi Screen Plus urine test strips. Their response, stating they contacted independent labs for validation, was deemed insufficient without supporting documentation like SOPs or evidence of implementation.

Additionally, the firm made significant modifications to CombiScreen urine test strips (adding (b)(4) to alter performance) and distributed CombiScreen 10SL Plus and CombiScreen 11 SYS Plus without submitting new

Company
Analyticon Biotechnologies AG
Inspection date
March 29, 2012
Product type
Devices
Office
Center for Devices and Radiological Health
Person
  • Alberto Gutierrez (Director)
View Company Profile

ID · 1f32460e-91e7-4203-a114-bc310645e426

Violation Codes10
21 U.S.C. 352(o)21 U.S.C. 360(k)21 CFR 807.81(b)21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.100(a)(1)21 CFR 820.72(a)21 U.S.C. 351(f)(1)(B)21 U.S.C. 360e(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Analyticon Biotechnologies AG
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.